Eliem Therapeutics, Inc. reported raising $5 Million in an initial SEC Form D filing, from an offering of $50 Million
Amount Raised
$5 Million
Round Type
Seed
Wellesley HillsBiotechnologyHealthcareHealth CareresearchWho else raised in Healthcare and research around the same time
Companies in the same sectors as Climb Bio, Inc. that raised within 45 days of this round, from Fundz verified event records.
- ReAlta Life Sciences raised $23M on December 18, 2020.
- TuHURA Biosciences raised $2.7M (Seed) on December 17, 2020.
- CytoDyn raised $1M (Seed) on December 16, 2020.
- CytoDyn raised an undisclosed amount on December 16, 2020.
- Azora Therapeutics, Inc. (DE) raised $296K on November 30, 2020.
- Insightec raised an undisclosed amount (Funding Round) on November 24, 2020.
Who to call at Climb Bio, Inc., and when
A new round usually means Climb Bio, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Climb Bio, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Climb Bio, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Climb Bio, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Climb Bio, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Climb Bio, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.